Fitbit CEO James Park on the struggles and future of the wearable maker

创业投资 TechCrunch (源链)

James Park is quick to admit that the Ionic was a disappointment. Fitbit’s co-founder and CEO refuses to disclose any specific numbers during our chat, but he acknowledges that the company’s first smartwatch isn’t the mainstream device it could have — or should have — been.

The sentiment is punctuated by the fact that the product felt like a Hail Mary at the time. As Fitbit’s fortune was declining, the executive began talking up the product well in advance of its release, as the company acquired several offerings to bolster the device.

Of course, that admission comes in the wake of this week’s product announcement. The Versa is the device the Ionic should have been. It’s a more mainstream product that makes a special effort to focus on a female user base, with added health features. It was a large demographic that was overlooked with the product, which likely proved too large for many wrists.

The Versa attempts to address the issue, as the company works to expand its reach even further. The company announced its first fitness tracker aimed at children aged eight to 17 and outlined its plan to shift more of its focus to the healthcare sector — a category that could provide more stable than the ongoing ups and down of consumer wearables.

TC: You started the event by discussing the shift the company is undergoing with regards to healthcare.

JP: We’ve historically been primarily focused on the consumer. We’ll continue to do that, but the shift we’re undergoing is taking what we’ve done and packaging it in such a way that it can be used by the healthcare system, so when we invest in a particular technology or service that it can by used that way. So, we’ll continue to develop our consumer revenue stream, but continue to develop healthcare as well.

TC: How fundamental of a shift is this for the company? Jawbone recently moved entirely in that direction. What percentage do you ultimately see the healthcare side making up the company’s revenue?

JP: It’s hard to state today. It’s too early to say what that percentage will be. But in the future, you should think of us as a hybrid company. We’re both consumer and healthcare. Doing both is really important. One of the challenges that healthcare has today is in the effective use of technology. A bigger problem they have is in engaging consumers — keeping them active and motivated to use these tools that are coming out. No one is really excited to interact with their hospital or healthcare provide. Our aim is to become a front end to the consumer healthcare system.

TC: Is it becoming too difficult to be successful as purely a consumer wearables company?

JP: I think we see it more as an untapped revenue stream — one that has more unstable revenue streams that are recurring and of a predictable nature. A lot of successful companies do this kind of hybrid. If you look at [Johnson & Johnson], for example, they have consumer products, but they also have a really amazing healthcare business that consumers may not know about. We as a company are looking to follow the same path, to grow as a company and also diversify our revenues.

TC: Was the Ionic as disappointment?

JP: It didn’t do [as] well as we wanted it to. We’re being pretty upfront about that. A large part of that had to do with the fact that, ultimately, it was a performance-oriented product. That audience is much smaller than a mass appeal device. I think the positive thing for us is that it outselling, at a similar stage, our Fitbit Surge device, which it is replacing. The hope with the Fitbit Versa is that this is our true mainstream device from a feature set, design and price perspective. This is a device for us to use as a means to gain a significant market share.

TC: Can you disclose specific numbers on the Ionic?

JP: No.

TC: You talked up the Ionic long before the launch of the device. The company was struggling and you were positioning the product as the one that would move the company in the right direction. Did you hype the device too much? Is the [Versa] the device that should have come out first?

JP: When we thought about our entry into smartwatches, it wasn’t about just one device. So, there was a portfolio plan. When you think about our acquisitions of Pebble, Vector and Coin, leveraging to really develop the Fitbit SDK, that software investment is one that’s going to be leveraged across a portfolio of devices, including the Versa. So, a lot of things you see today are launching on Versa, but they’re going to be available on Ionic, as well. That’s how we think about our investment in Versa. It’s not just about one device.

TC: So you’re still committed to the Ionic?

JP: Absolutely. When you launch into a category, you want to include a flagship device, which the Ionic is, from a pure feature set. But not we’re thinking about how to address the needs of a lot of other people.

TC: What’s the sense among the board as far as the health of the company and your role, versus a year ago?

JP: I think 2017 was a year that we had to take very quick action to stabilize the company and turn things around. I think we did that, and if you take a look at our 2017 guidance versus results, we did what we said we would. For the full year, we ended up meeting our guidance on revenue and actually doing a little better than we forecasted on free cash flow. We’re moving from losing money — about $25 million in 2017 — to be break-even on a free cash flow basis in 2018. So it shows that we’re stabilizing the company.

TC: What does the consumer side of wearables look like, moving forward?

JP: With the consumer side, what we’re seeing is a shift from fitness trackers to more fully featured devices like smartwatches. The launch of Ionic and Versa allows us to have a portfolio that takes advantage of that trend. We didn’t have the right mix of products in 2017, which is what hurt us as a company. But I think one of the places where that strategy is really succeeding is internationally. It’s about 40 percent of our revenue. The state of that industry is about a year behind the U.S., and you’re just starting to see that change from fitness trackers to smartwatches, but the good news internationally is that, as that transition is happening, we actually have the right set of products to mitigate the effects of the decline of the tracker market.

TC: On the tracker side of things, you’re competing with devices from companies like Xiaomi — $20 products. It’s hard to make a profit at that level.

JP: Actually, you’ll see that price hasn’t been a barrier for us on the low end. The average selling price has remained pretty stable. The combination of our brand and community helps us maintain our price points.

TC: When you talk about smartwatch growth, you’re primarily talking about Apple. It’s far and away the leader. What are you able to offer that the Apple Watch doesn’t?

JP: I think there’s benefits for consumers and the healthcare industry. For us, it’s about having devices that are focused on fitness. Cross-platform compatibility is a huge deal, battery life, the right features and price point. I think all of those things, along with our community of users. And if you think about fitness and healthcare, these are huge markets. There’s going to be room for more than one company to succeed.

TC:As the company was going through a difficult time, tough decisions had to be made. Obviously it’s never easy to let go of staff. Did you reconsider whether you’re still the best person to lead the company?

JP: The main thing for me is, I’m incredibly excited to come into work every day. I’m driven by the mission of the company. What we’re trying to do is build the right management team, including the board. My focus is taking my passion, building the right team around me and continuing to execute on the mission. The company has been around 11 years. We’ve had a lot of challenges, and I think the great thing is that we’ve been able to persevere through each one of them.

TC: You never had a moment of doubt, whether you were in the right position?

JP: To not have doubt is kind of crazy over 11 years. There’s always those moments when it’s tough. But the most important thing for me is whether I still have the passion.

TC: Is the company out of the woods?

JP: It’s too early to say that. I think what we’re showing through the past year is that we’ve stabilized and are looking to grow.

TC: Does the new dual focus on smart devices and healthcare mean we’re going to see fewer fitness band lines moving forward?

JP: We’re looking to streamline that category, but it’s going to continue to play an important role in the company. Whetherit’s kids or the healthcare system, or people who are more price conscious, trackers continue to play a role. But now we have a lineup that’s more diversified and better to meet people’s needs.

您可能感兴趣的

国产动漫行业巨头未现:90%以上的公司不盈利... 2015年国产动画电影《西游记之大圣归来》获得巨大成功,让不少投资人看到动画电影的潜力,热钱不断涌入,之前不少融资举步维艰的动画公司得到新的助推力。然而,由于缺乏高水准内容持续产出,动画公司的生存现状并未根本扭转,多位动画行业公司负责人表达着同样的观点,“90%以上的动画公司不盈利。” ...
聚美优品市值暴跌九成 合伙人离职替陈欧背黑锅?... 7月26日,聚美优品宣布副总裁戴雨森因个人原因辞职,即日生效。戴雨森在个人微博发长文《我们是永远的中国合伙人》以作告别,聚美优品3年市值缩水九成,现联合创始人离职,不禁让外界一时间猜疑四起。 文/彬彬(熊出墨请注意) 商务合作、约稿等,请加QQ:6991084 合伙人离职烟雾弹变现实 ...
500 Startups-backed Tamatem raises $2.5M to locali... Tamatem , a startup backed by 500 Startups that creates localised versions of popular games so that they resonate better with users in Arabic spea...
从入门到倒闭,共享汽车算是快黄了 别往多了说,不到半年前,大伙儿听到“共享”二字还都感觉这是个互联网新风口,未来新方向。但这词儿搁最近,几乎已经成为了“高运营成本,低回报,骗钱”的代名词。 共享单车倒得倒,黄得黄没剩几家,共享雨伞、雨衣、板凳、充电宝都跟玩儿闹似的说没就没,当初炒作刷了不少屏的共享汽车,也基本上彻底要完蛋了...
用人脉共享创造专属于你的伯乐,枣仁网希望用全新模式提高企业招聘效率... 9dfe3f36d4f9b80b4fd120487dfca14a 回顾国内招聘行业的发展,在2000年至2014年,几乎没有任何进展。那时候还是传统招聘巨头如智联招聘、前程无忧的天下。模式也很简单,企业在网站上发布职位,求职者若看重此职位,直接投递即可。简单粗暴,也难以称的上是有效。企业的痛...
TechCrunch责编内容来自:TechCrunch (源链) | 更多关于

阅读提示:酷辣虫无法对本内容的真实性提供任何保证,请自行验证并承担相关的风险与后果!
本站遵循[CC BY-NC-SA 4.0]。如您有版权、意见投诉等问题,请通过eMail联系我们处理。
酷辣虫 » Fitbit CEO James Park on the struggles and future of the wearable maker



专业 x 专注 x 聚合 x 分享 CC BY-NC-SA 4.0

使用声明 | 英豪名录